Cadmium Exposure and Incident Cardiovascular Disease
María Téllez-Plaza(Johns Hopkins University), Ana Navas‐Acién(University of Southern California), Jason G. Umans(MedStar Health), Eliseo Güallar(Spanish National Centre for Cardiovascular Research), Kevin A. Francesconi(University of Graz), Barbara V. Howard(National Institutes of Health), Walter Goessler(University of Graz), Richard B. Devereux(Cornell University), Ellen K. Silbergeld
Cited by 352
Related Papers
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Social Determinants of Health and Diabetes: A Scientific Review
|Diabetes Care|2020|1.6k
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|1.6k
Lead Exposure and Cardiovascular Disease—A Systematic Review
|Environmental Health Perspectives|2006|1.1k
Multimodality Imaging of Diseases of the Thoracic Aorta in Adults: From the American Society of Echocardiography and the European Association of Cardiovascular Imaging
|Journal of the American Society of Echocardiography|2015|624